A Mendelian randomization study of circulating uric acid and type 2 diabetes

Ivonne Sluijs; Michael V. Holmes; Yvonne T. Van Der Schouw; Joline W.J. Beulens; Folkert W. Asselbergs; José María Huerta; Tom M. Palmer; Larraitz Arriola; Beverley Balkau; Aurelio Barricarte; Heiner Boeing; Françoise Clavel-Chapelon; Guy Fagherazzi; Paul W. Franks; Diana Gavrila; Rudolf Kaaks; Kay Tee Khaw; Tilman Kühn; Esther Molina-Montes; Lotte Maxild Mortensen; Peter M. Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; J. Ramón Quirós; Olov Rolandsson; Carlotta Sacerdote; Núria Sala; Julie A. Schmidt; Robert A. Scott; Sabina Sieri; Nadia Slimani; Annemieke M.W. Spijkerman; Anne Tjonneland; Ruth C. Travis; Rosario Tumino; L. A. Van Der Daphne; Stephen J. Sharp; Nita G. Forouhi; Claudia Langenberg; Elio Riboli; Nicholas J. Wareham

doi:10.2337/db14-0742

A Mendelian randomization study of circulating uric acid and type 2 diabetes

Ivonne Sluijs^*, Michael V. Holmes, Yvonne T. Van Der Schouw, Joline W.J. Beulens, Folkert W. Asselbergs, José María Huerta, Tom M. Palmer, Larraitz Arriola, Beverley Balkau, Aurelio Barricarte, Heiner Boeing, Françoise Clavel-Chapelon, Guy Fagherazzi, Paul W. Franks, Diana Gavrila, Rudolf Kaaks, Kay Tee Khaw, Tilman Kühn, Esther Molina-Montes, Lotte Maxild MortensenPeter M. Nilsson, Kim Overvad, Domenico Palli, Salvatore Panico, J. Ramón Quirós, Olov Rolandsson, Carlotta Sacerdote, Núria Sala, Julie A. Schmidt, Robert A. Scott, Sabina Sieri, Nadia Slimani, Annemieke M.W. Spijkerman, Anne Tjonneland, Ruth C. Travis, Rosario Tumino, L. A. Van Der Daphne, Stephen J. Sharp, Nita G. Forouhi, Claudia Langenberg, Elio Riboli, Nicholas J. Wareham

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

85 Citations (Scopus)

Abstract

We aimed to investigate the causal effect of circulating uric acid concentrations on type 2 diabetes risk. A Mendelian randomization study was performed using a genetic score with 24 uric acid-associated loci. We used data of the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study, comprising 24,265 individuals of European ancestry from eight European countries. During a mean (SD) follow-up of 10 (4) years, 10,576 verified incident case subjects with type 2 diabetes were ascertained. Higher uric acid was associated with a higher diabetes risk after adjustment for confounders, with a hazard ratio (HR) of 1.20 (95% CI 1.11, 1.30) per 59.48 mmol/L (1 mg/dL) uric acid. The genetic score raised uric acid by 17 |xmol/L (95% CI15,18) per SD increase and explained 4% of uric acid variation. By using the genetic score to estimate the unconfounded effect, we found that a 59.48 n-mol/L higher uric acid concentration did not have a causal effect on diabetes (HR 1.01 [95% CI 0.87, 1.16]). Including data from the Diabetes Genetics Replication And Metaanalysis (DIAGRAM) consortium, increasing our dataset to 41,508 case subjects with diabetes, the summary odds ratio estimate was 0.99 (95% CI 0.92,1.06). In conclusion, our study does not support a causal effect of circulating uric acid on diabetes risk. Uric acid-lowering therapies may therefore not be beneficial in reducing diabetes risk.

Original language	English
Pages (from-to)	3028-3036
Number of pages	9
Journal	Diabetes
Volume	64
Issue number	8
DOIs	https://doi.org/10.2337/db14-0742
Publication status	Published - Aug 2015
Externally published	Yes

Access to Document

10.2337/db14-0742

Cite this

Sluijs, I., Holmes, M. V., Van Der Schouw, Y. T., Beulens, J. W. J., Asselbergs, F. W., Huerta, J. M., Palmer, T. M., Arriola, L., Balkau, B., Barricarte, A., Boeing, H., Clavel-Chapelon, F., Fagherazzi, G., Franks, P. W., Gavrila, D., Kaaks, R., Khaw, K. T., Kühn, T., Molina-Montes, E., ... Wareham, N. J. (2015). A Mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes, 64(8), 3028-3036. https://doi.org/10.2337/db14-0742

@article{c9c3c102e603457f800b9f7557a39e9b,

title = "A Mendelian randomization study of circulating uric acid and type 2 diabetes",

abstract = "We aimed to investigate the causal effect of circulating uric acid concentrations on type 2 diabetes risk. A Mendelian randomization study was performed using a genetic score with 24 uric acid-associated loci. We used data of the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study, comprising 24,265 individuals of European ancestry from eight European countries. During a mean (SD) follow-up of 10 (4) years, 10,576 verified incident case subjects with type 2 diabetes were ascertained. Higher uric acid was associated with a higher diabetes risk after adjustment for confounders, with a hazard ratio (HR) of 1.20 (95% CI 1.11, 1.30) per 59.48 mmol/L (1 mg/dL) uric acid. The genetic score raised uric acid by 17 |xmol/L (95% CI15,18) per SD increase and explained 4% of uric acid variation. By using the genetic score to estimate the unconfounded effect, we found that a 59.48 n-mol/L higher uric acid concentration did not have a causal effect on diabetes (HR 1.01 [95% CI 0.87, 1.16]). Including data from the Diabetes Genetics Replication And Metaanalysis (DIAGRAM) consortium, increasing our dataset to 41,508 case subjects with diabetes, the summary odds ratio estimate was 0.99 (95% CI 0.92,1.06). In conclusion, our study does not support a causal effect of circulating uric acid on diabetes risk. Uric acid-lowering therapies may therefore not be beneficial in reducing diabetes risk.",

author = "Ivonne Sluijs and Holmes, {Michael V.} and {Van Der Schouw}, {Yvonne T.} and Beulens, {Joline W.J.} and Asselbergs, {Folkert W.} and Huerta, {Jos{\'e} Mar{\'i}a} and Palmer, {Tom M.} and Larraitz Arriola and Beverley Balkau and Aurelio Barricarte and Heiner Boeing and Fran{\c c}oise Clavel-Chapelon and Guy Fagherazzi and Franks, {Paul W.} and Diana Gavrila and Rudolf Kaaks and Khaw, {Kay Tee} and Tilman K{\"u}hn and Esther Molina-Montes and Mortensen, {Lotte Maxild} and Nilsson, {Peter M.} and Kim Overvad and Domenico Palli and Salvatore Panico and Quir{\'o}s, {J. Ram{\'o}n} and Olov Rolandsson and Carlotta Sacerdote and N{\'u}ria Sala and Schmidt, {Julie A.} and Scott, {Robert A.} and Sabina Sieri and Nadia Slimani and Spijkerman, {Annemieke M.W.} and Anne Tjonneland and Travis, {Ruth C.} and Rosario Tumino and {Van Der Daphne}, {L. A.} and Sharp, {Stephen J.} and Forouhi, {Nita G.} and Claudia Langenberg and Elio Riboli and Wareham, {Nicholas J.}",

note = "Publisher Copyright: {\textcopyright} 2015 by the American Diabetes Association.",

year = "2015",

month = aug,

doi = "10.2337/db14-0742",

language = "English",

volume = "64",

pages = "3028--3036",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

number = "8",

}

Sluijs, I, Holmes, MV, Van Der Schouw, YT, Beulens, JWJ, Asselbergs, FW, Huerta, JM, Palmer, TM, Arriola, L, Balkau, B, Barricarte, A, Boeing, H, Clavel-Chapelon, F, Fagherazzi, G, Franks, PW, Gavrila, D, Kaaks, R, Khaw, KT, Kühn, T, Molina-Montes, E, Mortensen, LM, Nilsson, PM, Overvad, K, Palli, D, Panico, S, Quirós, JR, Rolandsson, O, Sacerdote, C, Sala, N, Schmidt, JA, Scott, RA, Sieri, S, Slimani, N, Spijkerman, AMW, Tjonneland, A, Travis, RC, Tumino, R, Van Der Daphne, LA, Sharp, SJ, Forouhi, NG, Langenberg, C, Riboli, E & Wareham, NJ 2015, 'A Mendelian randomization study of circulating uric acid and type 2 diabetes', Diabetes, vol. 64, no. 8, pp. 3028-3036. https://doi.org/10.2337/db14-0742

TY - JOUR

T1 - A Mendelian randomization study of circulating uric acid and type 2 diabetes

AU - Sluijs, Ivonne

AU - Holmes, Michael V.

AU - Van Der Schouw, Yvonne T.

AU - Beulens, Joline W.J.

AU - Asselbergs, Folkert W.

AU - Huerta, José María

AU - Palmer, Tom M.

AU - Arriola, Larraitz

AU - Balkau, Beverley

AU - Barricarte, Aurelio

AU - Boeing, Heiner

AU - Clavel-Chapelon, Françoise

AU - Fagherazzi, Guy

AU - Franks, Paul W.

AU - Gavrila, Diana

AU - Kaaks, Rudolf

AU - Khaw, Kay Tee

AU - Kühn, Tilman

AU - Molina-Montes, Esther

AU - Mortensen, Lotte Maxild

AU - Nilsson, Peter M.

AU - Overvad, Kim

AU - Palli, Domenico

AU - Panico, Salvatore

AU - Quirós, J. Ramón

AU - Rolandsson, Olov

AU - Sacerdote, Carlotta

AU - Sala, Núria

AU - Schmidt, Julie A.

AU - Scott, Robert A.

AU - Sieri, Sabina

AU - Slimani, Nadia

AU - Spijkerman, Annemieke M.W.

AU - Tjonneland, Anne

AU - Travis, Ruth C.

AU - Tumino, Rosario

AU - Van Der Daphne, L. A.

AU - Sharp, Stephen J.

AU - Forouhi, Nita G.

AU - Langenberg, Claudia

AU - Riboli, Elio

AU - Wareham, Nicholas J.

PY - 2015/8

Y1 - 2015/8

N2 - We aimed to investigate the causal effect of circulating uric acid concentrations on type 2 diabetes risk. A Mendelian randomization study was performed using a genetic score with 24 uric acid-associated loci. We used data of the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study, comprising 24,265 individuals of European ancestry from eight European countries. During a mean (SD) follow-up of 10 (4) years, 10,576 verified incident case subjects with type 2 diabetes were ascertained. Higher uric acid was associated with a higher diabetes risk after adjustment for confounders, with a hazard ratio (HR) of 1.20 (95% CI 1.11, 1.30) per 59.48 mmol/L (1 mg/dL) uric acid. The genetic score raised uric acid by 17 |xmol/L (95% CI15,18) per SD increase and explained 4% of uric acid variation. By using the genetic score to estimate the unconfounded effect, we found that a 59.48 n-mol/L higher uric acid concentration did not have a causal effect on diabetes (HR 1.01 [95% CI 0.87, 1.16]). Including data from the Diabetes Genetics Replication And Metaanalysis (DIAGRAM) consortium, increasing our dataset to 41,508 case subjects with diabetes, the summary odds ratio estimate was 0.99 (95% CI 0.92,1.06). In conclusion, our study does not support a causal effect of circulating uric acid on diabetes risk. Uric acid-lowering therapies may therefore not be beneficial in reducing diabetes risk.

AB - We aimed to investigate the causal effect of circulating uric acid concentrations on type 2 diabetes risk. A Mendelian randomization study was performed using a genetic score with 24 uric acid-associated loci. We used data of the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study, comprising 24,265 individuals of European ancestry from eight European countries. During a mean (SD) follow-up of 10 (4) years, 10,576 verified incident case subjects with type 2 diabetes were ascertained. Higher uric acid was associated with a higher diabetes risk after adjustment for confounders, with a hazard ratio (HR) of 1.20 (95% CI 1.11, 1.30) per 59.48 mmol/L (1 mg/dL) uric acid. The genetic score raised uric acid by 17 |xmol/L (95% CI15,18) per SD increase and explained 4% of uric acid variation. By using the genetic score to estimate the unconfounded effect, we found that a 59.48 n-mol/L higher uric acid concentration did not have a causal effect on diabetes (HR 1.01 [95% CI 0.87, 1.16]). Including data from the Diabetes Genetics Replication And Metaanalysis (DIAGRAM) consortium, increasing our dataset to 41,508 case subjects with diabetes, the summary odds ratio estimate was 0.99 (95% CI 0.92,1.06). In conclusion, our study does not support a causal effect of circulating uric acid on diabetes risk. Uric acid-lowering therapies may therefore not be beneficial in reducing diabetes risk.

UR - http://www.scopus.com/inward/record.url?scp=84943357645&partnerID=8YFLogxK

U2 - 10.2337/db14-0742

DO - 10.2337/db14-0742

M3 - Article

C2 - 25918230

AN - SCOPUS:84943357645

SN - 0012-1797

VL - 64

SP - 3028

EP - 3036

JO - Diabetes

JF - Diabetes

IS - 8

ER -

A Mendelian randomization study of circulating uric acid and type 2 diabetes

Abstract

Access to Document

Other files and links

Fingerprint

Cite this